Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

FOCUS BIOMOLECULES BRM014, BRM / BRG1 ATPase inhibitor, CAS# 2270879-17-7, >98% by HPLC_NMR (Conforms)
SDP

Supplier:  FOCUS BIOMOLECULES 1052441MG

Encompass_Preferred

Biochemical Reagents, BRM014, BRM / BRG1 ATPase inhibitor, CAS# 2270879-17-7, >98% by HPLC_NMR (Conforms), SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily A member 2 [SMARCA2, or Brahma homologue (BRM)], together with its close homologue Brahma-related gene 1 (BRG1), or SMARCA4, are ATPases of the large ATP-dependent SWI/SNF chromatin-remodeling complexes involved in transcriptional regulation of gene expression. Allosteric dual inhibitor of BRM & BRG1 (IC50<5 nM for both). It downregulated BRM-dependent gene expression and displayed antiproliferative activity in a BRG1-mutant-lung-tumor xenograft model after oral administration. Inhibition of BRG1/BRM ATPase by BRM014 inhibits chromatin openness. For example, it reduced DNA accessibility to core regulatory factors (RUNX1, LM01 and MEIS1) at transcription factor PU.1 sites in AML cells. P583 cells formed markedly large spheroids when treated with BRM014. Cell permeable and active in vivo.

Catalog No. NC3360313


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.